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Abstract.	
	
The objective of the research was to study serum levels of pro-inflammatory 
interleukin-8 and anti-inflammatory interleukin-4 in infants with complicated pneumonia 
depending on concomitant iron-deficiency as well as to establish their diagnostic value. 
Materials and methods. The levels of interleukin-4 and interleukin-8 were studied 
in 80 children with complicated pneumonia at the age of 2 months to 3 years, 60 out of 
them developed the condition secondary to iron-deficiency anemia. Children were divided 
into two groups: Group I included patients with complicated pneumonia without iron-
deficiency anemia; Group II consisted of patients with complicated pneumonia and 
concomitant iron-deficiency anemia. In addition, depending on the severity of iron-
deficiency anemia Group II was divided into three subgroups: IIa, IIb and IIc - a combination 
of pneumonia with anemia of mild, moderate and severe degrees, respectively. Serum levels 
of interleukin-4 and interleukin-8 were determined using enzyme-linked immunosorbent 
assay by means of standard kit (Vector-Best, Novosibirsk, Russia). 
Results.  Elevated levels of pro-inflammatory interleukin-8 and anti-inflammatory 
interleukin-4 were typical for all young children with acute complicated pneumonia 
(р<0.01). At the same time, in patients with complicated pneumonia secondary to iron-
deficiency anemia these parameters were significantly higher compared to those in 
children with complicated pneumonia without iron-deficiency anemia (р<0.001). In the 
convalescence period a significant reduction in the levels of interleukin-8 was observed in 
all groups of children, while the concentration of interleukin-4 increased significantly 
(р<0.001). 
Conclusions. Elevated levels of pro-inflammatory interleukin-8 and anti-
inflammatory interleukin-4 were typical for all young children in the acute phase of 
complicated pneumonia. At the same time, in patients with complicated pneumonia 
secondary to iron-deficiency anemia these parameters were significantly higher compared 
to those in children with complicated pneumonia without iron-deficiency anemia (р<0.001). 
In the convalescence period a significant reduction in the levels of interleukin-8 was 
observed in all groups of children (p<0.01); however, it did not reach the indicators of age 
norm (p<0.001), while the concentration of interleukin-4 increased significantly (p<0.001). 
In patients with complicated pneumonia secondary to severe iron-deficiency anemia 
changes in the concentrations of interleukin-8 and interleukin-4 were more significant 
compared to patients with complicated pneumonia without iron-deficiency anemia. 
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Problem statement and analysis of the recent research 
Despite the existing methods of prevention and treatment, respiratory diseases remain to be 
a significant burden in terms of infant morbidity and mortality. One of the most common diseases 
of childhood characterized by high mortality rates is pneumonia [1]. Despite numerous studies 
having been carried out in recent years, the pathogenesis of community-acquired pneumonia (CAP) 
is multi-faceted and not fully understood. Cases of pneumonia on the premorbid background or 
pneumonia with concomitant pathology are particularly noteworthy [2, 3, 4, 11]. An important role 
in the pathogenesis of inflammation in general and pneumonia in particular is played by cytokines 
reflecting the state of specific and nonspecific inflammatory reactions and being of great diagnostic 
and prognostic value. Cytokines are the initial link of activation of the immune response; they 
determine the effectiveness, type and duration of immune response to infectious agents as well as 
take a direct part in the regulation of immune protection [5, 6, 7, 8, 17]. 
In maintaining dynamic balance of factors of the immune protection in human organism a 
certain role is given to the system of pro- and anti-inflammatory interleukins [12, 13, 14]. It has been 
established that in the development of acute lung injury the level of many pro-inflammatory 
cytokines increases [15, 16, 17]. Their effect is associated with the expansion of blood vessels, increase 
in their permeability and fluid accumulation in the lungs tissues [6, 14].  
American scientists have proven that endotheliocytes of pulmonary capillaries are an 
important source of cytokines - IL-6 and IL-8 in the development of acute lung injury [15, 16]. 
Interleukin-8 (IL-8) plays one of the most important roles in the pathophysiology of acute lung injury. 
[15] Some researchers believe that the primary sources of IL-8 are the lungs, and it can be used for 
differential diagnosis of damage to the lungs and other organs [5, 7, 12]. In parallel with the activation 
of the system of pro-inflammatory cytokines the system of body anti-inflammatory response starts 
working. One of the most important anti-inflammatory cytokines is interleukin 4 (IL-4), which 
suppresses the production of pro-inflammatory cytokines [7, 16, 17]. IL-4 is mainly produced by 
stimulated T-helper cells and has a broad spectrum of activity promoting growth and differentiation 
of B-lymphocytes, activating macrophages, T lymphocytes and mast cells, inducing the production 
of class-specific immunoglobulins [5, 6, 16]. The therapeutic potential of cytokine is related to its 
ability to restore cellular and humoral immunity [8, 13, 14]. 
Thus, IL-4 and IL-8 take part in the infectious and inflammatory process at the level of effector 
mechanisms of immune response. It is the balance of pro- and anti-inflammatory cytokines that 
affects the clinical picture and the course of the disease, immunoregulatory and effector immune 
mechanisms [2, 12, 13, 14]. 
The objective of the research was to study serum levels of pro-inflammatory interleukin-8 
and anti-inflammatory interleukin-4 in infants with complicated pneumonia depending on 
concomitant iron-deficiency as well as to establish their diagnostic value. 
 
Materials and methods  
The study is based on the results of clinical and laboratory testing of 80 children with 
complicated pneumonia (CP) at the age from two months to three years who were treated in pediatric 
diagnostic department of Ivano-Frankivsk Regional Pediatric Hospital. 60 children were diagnosed 
with complicated pneumonia secondary to iron-deficiency anemia (IDA). To verify the diagnosis of 
CAP we have used clinical and anamnestic data and laboratory and instrumental tests according to 
unified clinical protocol of medical care “Pediatric pulmonology”, the Order of Ministry of Health of 
Ukraine of 13.01.2005 No 18 [10]. The severity of pneumonia in children at hospitalization was 
determined according to severity index and scale [1]. At admission to hospital severity index score 
was greater than 71, which corresponded to the index of necessity for the hospitalization. 
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The diagnosis of anemia and differential diagnosis to determine its genesis, severity and 
treatment were made according to the Order of Ministry of Health of Ukraine of 10.01.2005, No 9 [9]. 
Groups were formed randomly. 
Children were divided into two groups: Group I included patients with CP without IDA; Group 
II consisted of patients with CP and concomitant IDA. In addition, depending on the severity of iron-
deficiency anemia Group II was divided into three subgroups: IIa, IIb and IIc - a combination of 
pneumonia with anemia of mild, moderate and severe degrees, respectively. The control group 
consisted of 20 practically healthy children of the same age. 
 Studies were conducted during the acute phase of the disease (on the 1st-2nd days of the 
hospitalization) and during the early convalescence period and cessation of etiotropic treatment (on 
the 10th-14th days). 
Serum levels of interleukin-4 and interleukin-8 were determined using enzyme-linked 
immunosorbent assay by means of standard kits (Vector-Best, Novosibirsk, Russia). Normal values 
for IL-4 were (56.1±0.83) pg/ ml and for IL-8 - (23.77±0.59) pg/ml. 
 Statistical analysis of results was performed using licensed statistical packages Microsoft 
Excel and Statistica 5.5 including descriptive statistics programs; to determine the reliability the 
Student’s coefficient was used. 
 
Results and discussion 
The results of conducted investigations showed that in young children with CP there were 
some changes in the content of pro- and anti-inflammatory interleukins. 
In the acute phase of the disease the levels of IL-4 and IL-8 increased significantly: the level 
of anti-inflammatory interleukin increased by 2.22 times and the level of pro-inflammatory 
interleukin increased by 4.43 times compared to healthy children. At the onset of the disease the 
level of IL-8 in patients with CP without IDA increased to 105.59±2.24 pg/ml vs 23.77±0.59 pg/ml in 
children of the control group (p<0.001). Increased concentrations of pro-inflammatory interleukin-8 
can be explained as a reaction of cells of monocytic and macrophagal link to antigenic irritant. The 
concentration of IL-4 during the peak of the disease increased in patients with CP without IDA being 
80.08±1.48 pg/ml compared to the data of children of the control group – 36.21±0.83 pg/ml (p<0.001) 
(Table 1). The concentration of pro-inflammatory IL-8 during the early convalescence period 
decreased significantly (p <0.001); however, it remained at the high level (p<0.001), indicating the 
preservation of inflammation not only in the period of pronounced clinical manifestations but also 
in their absence. At the same time serum levels of anti-inflammatory interleukin-4 increased 
significantly (p<0.001) significantly exceeding the indices of healthy children (p<0.001) (Table 1) 
which probably indicates a decrease in the inflammatory process and a high level of activation of 
anti-inflammatory immune defense mechanisms. 
When analyzing the content of interleukin-8 at the onset of the disease we have found its 
significant increase in Group II compared to that in the control group (p<0.001) (Table 2). The 
concentration of interleukin-4 in patients of Group II also increased significantly (p<0.001). In patients 
of subgroup IIa an increase in interleukin-8 level was observed compared to indices of practically 
healthy children (p<0.001). The content of interleukin-4 in patients of subgroup IIa also increased 
compared to indices of children in the control group (p<0.001). Similar changes were observed in 
children with CP secondary to moderate IDA. In the acute phase of CP in patients of subgroup IIb 
concentration of interleukin-8 increased significantly compared to the data of children in the control 
group (p<0.001). In children of subgroup IIb serum level of interleukin-4 increased compared to that 
in healthy children (p<0.001). In patients of subgroup IIc concentration of interleukin-8 increased 
significantly compared to the data of children of subgroup IIa, subgroup IIb and the control group 
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(p<0.01). The level of interleukin-4 in patients of subgroup IIc increased compared to the data of 
healthy children (p<0.001) and children of subgroup IIa and subgroup IIb (p<0.01). 
 
Table 1 
Dynamics of serum levels of cytokines in infants with complicated pneumonia without iron-
deficiency anemia (M±m, pg/ml) 
 
Indices 
 
Control group 
n=20 
Children with CP without IDA 
(I) n=20 
before treatment after treatment 
ІL-4 36.21±0.83 80.08±1.48 
p1-2<0.001 
 
94.43±1.50 
p1-3<0.001 
p2-3<0.001 
ІL-8 23.77±0.59 105.59±2.24 
p1-2<0.001 
47.96±1.45 
p1-3<0.001 
p2-3<0.001 
Notes:  
p1–2– difference in indices between children of the main group and children of the control group at 
the start of treatment;  
p1–3 – difference in indices between children of the main group and children of the control group at 
the end of treatment; 
p2–3 – difference in indices between children of the main group and children of the control group at 
the start and the end of treatment 
  
Table 2 
Dynamics of serum levels of cytokines in infants with complicated pneumonia secondary to iron-
deficiency anemia (M±m, pg/ml) 
 
Index 
 
Control 
group, 
n=20 
Children with CP + mild 
IDA  
(subgroup IIa, n=20) 
Children with CP + 
moderate IDA  
(subgroup IIb, n=20) 
 Children with CP + 
severe IDA 
 (subgroup IIc, n=20) 
before 
treatment 
after 
treatment 
before 
treatment 
after 
treatment 
before 
treatment 
after 
treatment 
ІL-4 
 
36.21±0.8
3 
81.51±1.54 
γ 
99.10±2.11
"* 
90.23±0.79 
γ 
117.01±2.1
4"*° 
107.72±1.0
1 γ 
125.53±1.8
5"*°∆ 
ІL-8 23.77±0.5
9 
112.66±2.6
9 γ 
52.85±1.36
"* 
130.22±1.9
7 γ  
75.42±1.39"
*° 
146.74±3.0
7 γ 
84.26±1.17"
*°∆ 
Notes:  
γ - the reliability of difference in data between indices of the control group and each subgroup before 
treatment (p<0.001);  
“- reliability of difference in data between indices of the control group and each subgroup after 
treatment (p<0.001); 
* - the probability of difference in indices before and after treatment within one subgroup, (p<0.001); 
° - the probability of difference in indices between subgroups IIa, IIb, IIa, IIc after treatment, (p<0.01-
0.001);  
Δ – the probability of difference in indices between subgroup IIb and subgroup IIc after treatment, 
(p<0.01-0.001) 
  
Abnormal production, reception or secretion of inflammatory cytokines leads to profound 
defects in anti-infective protection up to the development of “immune paralysis” that enhances direct 
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damaging action of microorganisms and their toxins on the lung tissue. In addition, increased 
secretion of pro-inflammatory cytokines or imbalance of correlation between opposition pools can 
play an important role in the pathogenesis of pneumonia increasing aggregation of leukocytes to the 
vascular endothelium, stimulating its pro-coagulating activity and involving excess effector cells in 
inflammatory focus which ultimately enhances patho-immunological cascade and may lead to 
cytokine-mediated lung injury [2, 13, 14, 16]. 
Under the influence of treatment clinical and radiological recovery has been achieved: there 
has been a gradual improvement of children’ condition: (body temperature has normalized, appetite 
and sleep has improved, cough and catarrhal symptoms in the lungs as well as symptoms of 
respiratory failure have disappeared). An important objective treatment criterion was the elimination 
of pneumonic infiltration in control X-ray. However, the comparison of clinical and radiographic 
results with indices of cytokine levels indicated the preservation of inflammatory process activity. 
 In the convalescence period modified indicators improved; however, the expressiveness of 
these changes also depended on the presence of IDA. In patients with CP without IDA there was 
observed a significant reduction in interleukin-8 level compared to the index of the acute period 
(p<0.001). The level of interleukin-4 in this group of patients in the dynamics of treatment increased 
(p<0.01). However, the normalization of both indices was not observed (p<0.001). In children with CP 
and concomitant IDA there was observed a reduction in the level of interleukin-8 being significantly 
lower than indices in patients in the acute period (p <0.001), but higher than those in children of the 
control group (p<0.001) and patients with CP without IDA (p<0.05) (Table. 2). In patients suffering 
from CP with concomitant IDA there was observed an increase in serum levels of IL-4 level compared 
to those in patients in the acute period (p<0.001), practically healthy children (p<0.001) and children 
with CP without IDA (p<0.01). 
 In the early convalescence period IL-8 level remained to be elevated in the absence of clinical 
manifestations of the disease indicating incompleteness of the inflammatory process. The synthesis 
of anti-inflammatory IL-4 in the dynamics of the disease significantly increased, particularly in 
concomitant iron-deficiency anemia, which may indicate the structural rebuilding of the immune 
response towards the anti-inflammatory direction as well as normal course of inflammation with 
stimulation of humoral, cellular and local defenses [16]. 
  
Conclusions 
 Elevated levels of pro-inflammatory interleukin-8 and anti-inflammatory interleukin-4 were 
typical for all young children in the acute phase of complicated pneumonia. At the same time, in 
patients with complicated pneumonia secondary to iron-deficiency anemia these parameters were 
significantly higher compared to those in children with complicated pneumonia without deficiency 
anemia (р<0.001). 
In the convalescence period a significant reduction in the levels of interleukin-8 was observed 
in all groups of children (p<0.01); however, it did not reach the indicators of age norm (p<0.001), while 
the concentration of interleukin-4 increased significantly (p<0.001). In patients with complicated 
pneumonia secondary to severe iron-deficiency anemia changes in the concentrations of interleukin-
8 and interleukin-4 were more significant compared to patients with complicated pneumonia 
without iron-deficiency anemia. 
 
Prospects for further research include the study of the dynamics of inflammation activity in 
children with complicated pneumonia secondary to iron-deficiency anemia during treatment 
including plant flavonoid medicine Immunoflazid. 
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